While acting on panic never helps investors, it's still a good idea to play devil's advocate with investments.
Consider robotic-surgery system maker Intuitive Surgical
Here at The Motley Fool, we like to consider both the good and bad sides of an investment. After you read this article highlighting three of the main bearish arguments on Intuitive Surgical, be sure to read the bullish side as well. Then weigh in with your comments below or rate Intuitive Surgical in CAPS.
While many CAPS members like Intuitive Surgical's strong fundamentals and growth potential, a good many also think its shares are overvalued. More diversified companies with medical equipment sales, such as Johnson & Johnson
2. Health-care changes
Some investors see added risk among medical device and drug companies because of potential changes from the new health-care law. Drug companies with big U.S. exposure, such as Eli Lilly
3. Global slowdown
Hospital spending has shown some improvement in the U.S.; companies such as medical-device maker Cepheid
To see details of what CAPS members are saying now about Intuitive Surgical, just click on over to Motley Fool CAPS and have a look, or add your thoughts directly to this story in the comments box below.
Always looking ahead, the Motley Fool Rule Breakers service is picking the next generations' big winners today. To see what other rule-breaking stocks David Gardner is recommending now, take a free 30-day trial.
Fool contributor Dave Mock votes 3 to be the number of the day. He owns shares of Johnson & Johnson, which is an Income Investor pick. Stryker is an Inside Value pick. Intuitive Surgical is a Rule Breakers choice. The Fool owns shares of and has written puts on Medtronic. Motley Fool Options has recommended a buy calls position on Johnson & Johnson. The Fool owns shares of Stryker. The Fool's disclosure policy quacks like a duck, but isn't a duck.